L27.1
Localized skin eruption due to drugs and medicaments taken internally
Clinical Classification Guidelines
Use Additional Code
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Medical Intelligence & Overview
ICD-10 code L27.1 refers to a localized skin eruption caused by the intake of drugs and medications. This condition presents as an inflammatory reaction on the skin's surface, confined to specific areas rather than being widespread. It is a form of drug allergy or hypersensitivity that manifests as skin irritation, often appearing soon after starting a new medication or increasing the dosage of an existing one. Recognizing the signs and understanding potential causes can aid in managing and preventing further skin reactions.
Causes & Symptoms
Clinical Causes: Use of certain medications, including antibiotics, anticonvulsants, and nonsteroidal anti-inflammatory drugs (NSAIDs) Use of topical medications or medicated creams that induce localized reactions Allergic response to excipients or inactive ingredients in medications Recent initiation of new medication therapy Dose escalation or changes in medication formulations Repeated exposure to the same or similar drugs leading to hypersensitivity
Key Symptoms: Redness or erythema confined to specific skin areas Localized swelling or inflammation Presence of small bumps, papules, or vesicles Itching or burning sensations in the affected areas Possible development of blistering or skin erosion in severe cases Skin discoloration or hyperpigmentation after resolution
Diagnostic & Treatment
Diagnosis Path: Diagnosis primarily involves a detailed medical history review to identify recent medication use and timing of skin reactions. Physical examination assesses the extent and appearance of the skin eruption. In some cases, patch testing or skin allergy testing may be performed to confirm hypersensitivity to specific drugs. Laboratory tests are generally not required unless systemic allergic reactions or other complications are suspected.
Treatment Protocols: Management typically includes discontinuation of the suspected medication and symptomatic relief through topical corticosteroids to reduce inflammation and antihistamines to alleviate itching. Patients are advised to avoid the offending drug and report any new or worsening symptoms. In severe cases, or where systemic allergic reactions are involved, healthcare providers may recommend additional interventions such as systemic corticosteroids or antihistamines. Follow-up is essential to monitor skin healing and prevent recurrence.
Clinical Advice & FAQs
Billing Guidance
Is L27.1 a billable ICD-10 code?
Yes, L27.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report L27.1?
Clinical documentation must specify the nature of Localized skin eruption due to drugs and medicaments taken internally and any associated comorbidities for accurate reporting.
Cite this Clinical Reference